A Comprehensive Review on Therapeutic Potential of a Natural Anthraquinone Derivative Emodin in Brain-related Disorders

被引:0
|
作者
Goyal, Ahsas [1 ]
Murti, Yogesh [1 ]
Bhushan, Bharat [1 ]
Chisti, Wasim [1 ]
Solanki, Ashutosh [2 ]
机构
[1] GLA Univ, Inst Pharmaceut Res, 17 Km Stone,NH-2 Mathura Delhi Highway,PO Chaumuha, Mathura 281406, UP, India
[2] Anand Coll Pharm SGI, Dept Pharmacol, Agra 282007, UP, India
关键词
EM; Alzheimer's disease; parkinson's disease; stress; epilepsy; depression; cerebral ischemia; glioblastoma; intra-cerebral haemorrhage; traumatic brain injury; ALOE-EMODIN; NEUROPATHIC PAIN; GLIOMA-CELLS; PC12; CELLS; RAT MODEL; KAPPA-B; APOPTOSIS; INJURY; RECEPTOR; MICE;
D O I
10.2174/1389450124666230818092506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Brain-related disorders are one of the world's most important and complex health problems today. These brain-related disorders are responsible for a massive number of morbidities and death all around the world. However, researchers have devoted a large amount of time to investigating these diseases and found positive results; nevertheless, there are currently quite a few medications available to treat them. Emodin (EM), a polyphenol compound, has many health benefits. It is a biologically active monomer derived from rhubarb root that exhibits anti-inflammation, anti-oxidation, anticancer, and neuroprotective properties. A series of preclinical trials have shown EM to have protective benefits against many brain-related diseases. This review has evaluated the potential of EM as a pharmacological agent for the treatment and management of various brain-related disorders based on the findings of multiple pre-clinical studies and taking into account the compound's therapeutic properties.
引用
下载
收藏
页码:945 / 958
页数:14
相关论文
共 50 条
  • [1] The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence
    Schon, Martin
    Mousa, Aya
    Berk, Michael
    Chia, Wern L.
    Ukropec, Jozef
    Majid, Arshad
    Ukropcova, Barbara
    de Courten, Barbora
    NUTRIENTS, 2019, 11 (06)
  • [2] The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin
    CUI Ya
    CHEN Liu-Jing
    HUANG Tu
    YING Jian-Qiong
    LI Juan
    Chinese Journal of Natural Medicines, 2020, 18 (06) : 425 - 435
  • [3] The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin
    Cui Ya
    Chen Liu-Jing
    Huang Tu
    Ying Jian-Qiong
    Li Juan
    CHINESE JOURNAL OF NATURAL MEDICINES, 2020, 18 (06) : 425 - 435
  • [4] A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders
    Goyal, Ahsas
    Singh, Geetanjali
    Verma, Aanchal
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (06) : 789 - 800
  • [5] Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review
    Singh, Niraj Kumar
    Bhushan, Bharat
    Singh, Pranjul
    Sahu, Kantrol Kumar
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
  • [6] Emodin-A natural anthraquinone derivative with diverse pharmacological activities
    Semwal, Ruchi Badoni
    Semwal, Deepak Kumar
    Combrinck, Sandra
    Viljoen, Alvaro
    PHYTOCHEMISTRY, 2021, 190
  • [7] The Roles of hnRNP Family in the Brain and Brain-Related Disorders
    Caroline Brandão-Teles
    André S. L. M. Antunes
    Talita Aparecida de Moraes Vrechi
    Daniel Martins-de-Souza
    Molecular Neurobiology, 2024, 61 : 3578 - 3595
  • [8] The Roles of hnRNP Family in the Brain and Brain-Related Disorders
    Brandao-Teles, Caroline
    Antunes, Andre S. L. M.
    Vrechi, Talita Aparecida de Moraes
    Martins-de-Souza, Daniel
    MOLECULAR NEUROBIOLOGY, 2024, 61 (06) : 3578 - 3595
  • [9] Brain Catalog: a comprehensive resource for the genetic landscape of brain-related traits
    Pan, Siyu
    Kang, Hongen
    Liu, Xinxuan
    Lin, Shiqi
    Yuan, Na
    Zhang, Zhang
    Bao, Yiming
    Jia, Peilin
    NUCLEIC ACIDS RESEARCH, 2023, 51 (D1) : D835 - D844
  • [10] The Brain Endothelin System as Potential Target for Brain-Related Pathologies
    Schinelli, Sergio
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (06) : 544 - 554